Skip to main content Accessibility help

Risk Factors for Development of Intestinal Colonization with Imipenem-Resistant Pseudomonas aeruginosa in the Intensive Care Unit Setting

  • Anthony D. Harris (a1) (a2), J. Kristie Johnson (a3), Kerri A. Thom (a1) (a2), Daniel J. Morgan (a1) (a2), Jessina C. McGregor (a4), Adebola O. Ajao (a1), Anita C. Moore (a1), Angela C. Comer (a1) and Jon P. Furuno (a1)...


Risk factors for development of intestinal colonization by imipenem-resistant Pseudomonas aeruginosa (IRPA) may differ between those who acquire the organism via patient-to-patient transmission versus by antibiotic selective pressure. The aim of this study was to quantify potential risk factors for the development of IRPA not due to patient-to-patient transmission.


Corresponding author

University of Maryland School of Medicine, Department of Epidemiology and Public Health, 685 West Baltimore Street, Room 330, Baltimore, MD 21201 (


Hide All
1.Hidron, AI, Edwards, JR, Patel, J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol 2008;29:9961011.
2.Bonten, MJ, Slaughter, S, Ambergen, AW, et al. The role of “colonization pressure” in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med 1998;158:11271132.
3.Lepelletier, D, Caroff, N, Riochet, D, et al. Role of hospital stay and antibiotic use on Pseudomonas aeruginosa gastrointestinal colonization in hospitalized patients. Eur J Clin Microbiol Infect Dis 2006;25:600603.
4.Pena, C, Guzman, A, Suarez, C, et al. Effects of carbapenem exposure on the risk for digestive tract carriage of intensive care unit-endemic carbapenem-resistant Pseudomonas aeruginosa strains in critically ill patients. Antimicrob Agents Chemother 2007;51:19671971.
5.Johnson, JK, Smith, G, Lee, MS, et al. The role of patient-to-patient transmission in the acquisition of imipenem-resistant Pseudomonas aeruginosa colonization in the intensive care unit. J Infect Dis 2009;200:900905.
6.Harris, AD, Karchmer, TB, Carmeli, Y, Samore, MH. Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review. Clin Infect Dis 2001;32:10551061.
7.Lankford, MG, Collins, S, Youngberg, L, Rooney, DM, Warren, JR, Noskin, GA. Assessment of materials commonly utilized in health care: implications for bacterial survival and transmission. Am J Infect Control 2006;34:258263.
8.Panagea, S, Winstanley, C, Walshaw, MJ, Ledson, MJ, Hart, CA. Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces. J Hosp Infect 2005;59:102107.
9.Kollef, MH. Broad-spectrum antimicrobials and the treatment of serious bacterial infections: getting it right up front. Clin Infect Dis 2008;47(suppl 1):S3S13.
10.Thom, KA, Johnson, JA, Strauss, SM, Furuno, JP, Perencevich, EN, Harris, AD. Increasing prevalence of gastrointestinal colonization with ceftazidime-resistant gram-negative bacteria among intensive care unit patients. Infect Control Hosp Epidemiol 2007;28:12401246.


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed